NextSeq 2000 System
Supports a wide range of methods such as exome sequencing, target enrichment, single-cell profiling, and transcriptome sequencing.
Join the virtual event | Wednesday, October 9, 9 AM (PT)
Illumina instruments offer an innovative portfolio of proven technology designed to meet a wide range of throughput and application needs. Featured in over 369,000 publications, Illumina instruments are trusted by research and clinical labs. Go from data to insights faster and easier than ever with unparalleled global support and service and comprehensive, accurate, and user-friendly bioinformatics tools.
Our innovative next-generation sequencing platforms deliver exceptional data quality and accuracy for a range of research needs and scales.
With easy-to-follow workflows and integrated software, our in vitro diagnostic (IVD) instruments deliver accurate, reliable results for diagnostic screening and testing.
Our array scanning systems provide rapid, sensitive, and accurate imaging of microarrays for exceptional genetic analysis results.
* For in vitro diagnostic use. Contact an Illumina representative for regional availability.
Supports a wide range of methods such as exome sequencing, target enrichment, single-cell profiling, and transcriptome sequencing.
Offers deep and broad coverage through advanced applications for a comprehensive view of the genome.
Combines tried-and-true instrument technologies and tunable output with sequencing and array capabilities.
The latest informatics tools help scientists gain insights from a growing body of complex genomic data. Assemble an effective bioinformatics solution with an entire ecosystem that spans infrastructure setup, data analysis, interpretation, automation, and sharing with collaborators.
Get a demo of the instrument that you are interested in or contact a specialist to get your questions answered. Fill out a request form and we will be in touch shortly.
Your email address is never shared with third parties.
Your email address is never shared with third parties.